Finance

Lists
Why is 531146 down 2,83%?
Dive Deeper
531146:BOM
Medicamen Biotech Ltd
288,55 INR
-2,83%
(-8,40) 1D
16-окт., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 531146...
Open
287,00 INR
High
290,00 INR
Low
282,15 INR
Mkt. cap
3,87 млд
Avg. vol.
5,49 миң
Volume
885,00
Dividend
0,35%
Quarterly dividend
0,25 INR
Ex-dividend date
2026-ж., 18-сен.
P/E ratio
33,23
52-wk high
454,00 INR
52-wk low
210,10 INR
EPS
8,68 INR
Shares outstanding
11,70 млн
No. of employees
405
Open
287,00 INR
High
290,00 INR
Low
282,15 INR
Mkt. cap
3,87 млд
Avg. vol.
5,49 миң
Volume
885,00
Dividend
0,35%
Quarterly dividend
0,25 INR
Ex-dividend date
2026-ж., 18-сен.
P/E ratio
33,23
52-wk high
454,00 INR
52-wk low
210,10 INR
EPS
8,68 INR
Shares outstanding
11,70 млн
No. of employees
405
News stories
From web sources and news partners
About Medicamen Biotech Ltd
CEO-
Employees405
Founded1993
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
475,43 млн
474,43 млн
592,69 млн
487,58 млн
Cost of goods sold
231,53 млн
237,10 млн
349,40 млн
211,20 млн
Cost of revenue
231,53 млн
237,10 млн
349,40 млн
211,20 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
88,31 млн
83,73 млн
146,78 млн
93,14 млн
Operating expense
207,18 млн
206,51 млн
219,99 млн
242,38 млн
Total operating expenses
438,71 млн
443,61 млн
569,39 млн
453,58 млн
Operating income
36,72 млн
30,83 млн
23,30 млн
34,01 млн
Other non operating income
-
1,00 миң
8,26 млн
-
EBT including unusual items
26,83 млн
21,11 млн
50,60 млн
25,72 млн
EBT excluding unusual items
26,83 млн
21,11 млн
50,56 млн
25,72 млн
Income tax expense
5,69 млн
4,76 млн
6,13 млн
7,26 млн
Effective tax rate
21,19%
22,56%
12,11%
28,22%
Other operating expenses
100,30 млн
104,51 млн
55,88 млн
131,37 млн
Net income
26,67 млн
21,87 млн
37,39 млн
21,18 млн
Net profit margin
5,61%
4,61%
6,31%
4,34%
Earnings per share
-
-
-
-
Interest and investment income
-
-
17,39 млн
-
Interest expense
-9,89 млн
-9,72 млн
-3,83 млн
-8,29 млн
Net interest expenses
-9,89 млн
-9,72 млн
13,56 млн
-8,29 млн
Depreciation and amortization charges
18,57 млн
18,27 млн
17,33 млн
17,87 млн
EBITDA
55,01 млн
48,10 млн
40,92 млн
52,05 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору